Companies such as Medtronic (Ireland), Boston Scientific Corporation (U.S.), Abbott (U.S.), Axogen Corporation (U.S.) and Baxter (U.S.) are the major companies in the nerve repair biomaterials market.
In October 2024, Integra LifeSciences announced the launch of SurgiMend PRS Meshed Collagen Matrix, designed for plastic and reconstructive surgery. While this product is primarily indicated for soft tissue reconstruction, its collagen matrix technology may have implications for nerve repair applications, providing a scaffold that supports tissue regeneration. In September 2024, Stryker Corporation announced the completion of its acquisition of NICO Corporation, a privately held company specializing in minimally invasive surgery for brain tumor removal and stroke care. This strategic acquisition is expected to enhance Stryker's capabilities in the nerve repair and regeneration market by integrating NICO's innovative technologies into its existing portfolio.
The countries covered in the nerve repair biomaterials market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.